Cited by 56Smoking Behavior and CessationGenetic Associations and EpidemiologyNicotinic Acetylcholine Receptors Study

Gamma-aminobutyric acid receptor genes and nicotine dependence: evidence for association from a case-control study

Agrawal, Arpana, Pergadia, Michele L., Saccone, Scott F., Hinrichs, Anthony L., Lessov‐Schlaggar, Christina N., Saccone, Nancy L., Neuman, Rosalind J., Breslau, Naomi +9 more·2008·Addiction

Abstract

AIMS: The gamma-aminobutyric acid receptor A (GABRA) gene clusters on chromosomes 4 and 5 have been examined previously for their association with alcohol and drug dependence phenotypes. Compelling evidence suggests that GABRA2 is associated with alcohol and drug dependence. However, no study has investigated whether genes in the GABA(A) gene clusters are associated with nicotine dependence, an important phenotype with a high correlation to persistent smoking, the single most preventable cause of mortality world-wide. DESIGN: Using data on 1050 nicotine-dependent cases and 879 non-dependent smoking controls, we used logistic regression to examine the association between single nucleotide polymorphisms (SNPs) in 13 genes in the GABA(A) receptor system as well as GABBR2 (a GABA(B) gene). FINDINGS: We found evidence for association between four SNPs in GABRA4, two SNPs in GABRA2 and one SNP in GABRE with nicotine dependence. These included a synonymous polymorphism in GABRA2 (rs279858), lying in a highly conserved region, which has been shown previously to be associated with alcohol and drug dependence. A non-synonymous polymorphism (rs16859834/rs2229940) in GABRA4, also highly conserved, was associated at P-value of 0.03. Significant haplotypes associated with nicotine dependence were found for GABRA2. No evidence for epistatic interactions were noted. Our study did not find evidence for an association between GABBR2 gene and nicotine dependence. CONCLUSIONS: Given the potential role of compounds that enhance GABAergic neurotransmission in smoking cessation research, these findings have enormous potential for informing the wider field of addiction research.

Integrity signals

Registry

Crossref · 10.1111/j.1360-0443.2008.02236.x

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • GABAARs in brain reward circuits may be involved in the development of brain changes that mediate the addictive properties of drugs in general.

    “The involvement of GABAAR genes in the abuse of and dependence on drugs that do not directly affect the GABAARs suggest that the GABAARs in brain reward circuits may be involved in the development of brain changes that mediate the addictive properties of drugs in general.”

    From An emerging circuit pharmacology of GABAA receptors (2018) · cites this paper as [102]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Agrawal, A., Pergadia, M. L., Saccone, S. F., Hinrichs, A. L., Lessov‐Schlaggar, C. N., Saccone, N. L., Neuman, R. J., Breslau, N., Johnson, E., Hatsukami, D., Montgomery, G. W., Heath, A. C., Martin, N. G., Goate, A. M., Rice, J. P., Bierut, L. J., & Madden, P. A. F.
Affiliations
  • Washington University in St. Louis (US)
  • SRI International (US)
  • Michigan State University (US)
  • RTI International (US)
  • University of Minnesota (US)
  • QIMR Berghofer Medical Research Institute (AU)
Venue
Addiction
Publisher
Wiley
Published
2008-06
Volume
103
Issue
6
Pages
1027-1038
ISSN
  • 0965-2140 (ISSN-L)
  • 1360-0443
OpenAlex
W2133217404
Cited by
56
References
68
Citations by year
2026: 1 · 2025: 2 · 2024: 1 · 2023: 3 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 7 · 2017: 1 · 2016: 7 · 2015: 3 · 2014: 3 · 2013: 1 · 2012: 3
FWCI
4.07
Type
journal article
Language
en
Open access
closed
Locations
  • Addiction (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • U.S. Public Health Service (HHSN271200477471C)
  • National Institute on Drug Abuse (DA 019951, DA12854, DA015129, N01DA07079, K01DA015129, K08DA019951)
  • National Cancer Institute (CA89392, P01CA089392)
Topics
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
Keywords
nicotine dependence, GABRA2, GABRA4, GABBR2, single nucleotide polymorphisms, haplotypes, smoking, genetic association, GABAergic neurotransmission, addiction genetics
MeSH terms
Chromosomes, Human, 4-5, Female, Genotype, Humans, Male, Phenotype, Tobacco Use Disorder, Logistic Models, Case-Control Studies, Smoking Cessation, Behavior, Addictive, Receptors, GABA, Evidence-Based Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review